Regulatory Updates
New post-approval initiatives for therapeutic products
Audiences
Industry member
Product type
Therapeutic Products
6 May 2020
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
The Therapeutic Products Branch (TPB), Health Products Regulation Group, is pleased to share the following new post-approval initiatives.
1) Summary Report of Benefit-Risk Assessment
2) New Online Form for Submission of Documents to Fulfil Registration Conditions
Click here [PDF, 449 KB] for more information.